Karyopharm Therapeutics  logo
Karyopharm Therapeutics KPTI
$ 0.79 1.02%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Karyopharm Therapeutics EV/EBITDA Ratio 2011-2024 | KPTI

Annual EV/EBITDA Ratio Karyopharm Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-8.17 -6.67 -5.21 -2.63 -3.71 -3.05 -1.38 -8.94 -1.32 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.32 -8.94 -4.57